Search

The White House is urging nursing home clinicians to make COVID-19 prevention and treatment drugs a more routine part of clinical care, as older adults continue to face an outsized [...]

Pfizer Inc. announced an agreement to supply up to six million treatment courses of its Covid-19 oral treatment, Paxlovid (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) to Global Fund as part [...]

The Covid treatment Paxlovid significantly reduces hospitalizations and deaths among older patients, new research from Israel suggests. The study is one of the first to examine the drug’s effectiveness against [...]

Global Banking News-September 22, 2022-Pfizer to supply up to 6 million Paxlovid treatments to Global Fund (C)2022 ENPublishing - http://www.enpublishing.co.uk US pharmaceutical company Pfizer Inc (NYSE:PFE) said on Thursday that [...]

Pfizer announced an agreement to supply up to six million treatment courses of its COVID-19 oral treatment, Paxlovid tablets and ritonavir tablets to Global Fund as part of its COVID-19 [...]

Dysguesia is 12 times more likely to occur in patients with COVID-19 treated with Paxlovid vs other therapeutics. Furthermore, COVID-19 dysguesia is more likely to occur in female vs male [...]

By Jamie Ducharme / HEALTH CORRESPONDENT A person holds Pfizer’s antiviral COVID-19 treatment Paxlovid PAXLOVID, THE ANTIVIRAL DRUG touted for its ability to keep high-risk COVID-19 patients out of the [...]

In a letter dated August 5, the FDA asked Pfizer (PFE) to conduct a clinical trial in patients with 'COVID-19 rebound' and a clinical trial evaluating different durations of treatment [...]

President Joe Biden offered his friend, Sen. Tom Carper, medical advice after they both got COVID. The Delaware Democrat said Biden told him to take Paxlovid. Biden got a 'rebound' [...]

President Joe Biden tested negative for COVID-19 on Saturday after rebound case. Biden will continue his isolation in the White House pending the results of a second antigen test. He [...]

HealthDay News — President Joe Biden is back in isolation and has tested positive for COVID-19 for the second day in a row, as he experiences what is known as [...]

FY22 consensus $6.62. Backs FY22 revenue view $98B-$102B, consensus $102.92B. Reaffirms 2022 Revenue guidance for Comirnaty and Paxlovid of ~$32B and ~$22B, [...]

The Food and Drug Administration (FDA) has authorized a 3-month extension to the shelf-life of 4 lots of Paxlovid (nirmatrelvir tablets and ritonavir tablets co-packaged for oral use) that were [...]

After five days following CDC guidelines, President Joe Biden has tested negative for COVID-19. President Biden tested positive for the virus Thursday. He completed a five-day Paxlovid course, according to [...]

The oral antiviral drugs molnupiravir and nirmatrelvir–ritonavir (Paxlovid) appear to reduce the risk of death from COVID-19 in patients with mild to moderate disease and may be most useful in [...]

Byline: Adina Genn Thanks to a partnership between Mount Sinai South Nassau and the Town of Hempstead, eligible patients testing positive for COVID can get the antiviral oral medication Paxlovid [...]

President Joe Biden tested positive for COVID-19 last week. (https://www.cnn.com/2022/07/22/politics/joe-biden-covid/index.html) He's expected to fully recover and his symptoms are reportedly 'mild,' though people have long debated (https://www.healthline.com/health-news/what-its-like-to-have-a-mild-covid-19-case#What-can-mild-COVID-feel-like?) just how 'mild' [...]

President Biden tested positive for COVID-19 on Thursday. The White House said he is 'experiencing very mild symptoms.' Experts say that Biden's fully vaccinated and twice-boosted status bodes well for [...]

Codexis (CDXS) announced that the company has entered into an agreement with Pfizer (PFE) for the supply of a proprietary enzyme used to manufacture a critical intermediate for nirmatrelvir, an [...]

Pharmacists now allowed to prescribe Paxlovid; new dosing recommendations for Evusheld; abuse-deterrent opioid analgesic; Priority Review for early Alzheimer disease treatment; morphine tablets [...]

State-licensed pharmacists can now prescribe Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) with certain limitations to eligible patients, according to the Food and Drug Administration (FDA). Paxlovid is authorized for [...]

HealthDay News — New York City’s Mayor Eric Adams https://www1.nyc.gov/office-of-the-mayor/news/465-22/mayor-adams-launches-nation-s-first-mobile-test-treat-program-provide-immediate-access-to Thursday that the city has launched the first-of-their-kind mobile COVID-19 testing units that will also dispense the antiviral drug Paxlovid [...]

The New Drug Application (NDA) for Paxlovid[sup.™] has been submitted to the Food and Drug Administration (FDA). Pfizer is seeking approval of the oral antiviral therapy for both vaccinated and [...]

Global Banking News-June 30, 2022-Pfizer seeks full FDA approval of Paxlovid (C)2022 ENPublishing - http://www.enpublishing.co.uk US biopharmaceutical company Pfizer Inc (NYSE:PFE) said on Thursday that it has submitted a New [...]

Additional findings were announced from a phase 2/3 study evaluating the efficacy and safety of Paxlovid™ (nirmatrelvir tablets co-packaged with ritonavir tablets) in patients with COVID-19 who are at standard [...]

Pfizer Inc. shared data from the phase 2/3 EPIC-SR (Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients) study evaluating the use of Paxlovid (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) [...]

Additional findings were announced from a phase 2/3 study evaluating the efficacy and safety of Paxlovid™ (nirmatrelvir tablets co-packaged with ritonavir tablets) in patients with COVID-19 who are at standard [...]

Pfizer 'shared data from the Phase 2/3 EPIC-SR study evaluating the use of PAXLOVID in patients who are at standard risk for developing severe COVID-19. In previously reported interim analyses, [...]

The Food and Drug Administration has updated its screening guidance for use of the COVID-19 antiviral pill Paxlovid. In changes published late last week, the agency urged prescribers to review [...]

Pfizer Inc. announced that it will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling US-based production in support of [...]

(HealthDay News) — Getting a hold of the COVID-19 antiviral treatment Paxlovid could get easier, the White House announced on Thursday. “We want to make Paxlovid as widely available across [...]

Pfizer announced that it will 'further strengthen its commitment' to United States manufacturing with a $120M investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 [...]